FDA Expands Warning on Moringa Capsules Linked to Salmonella Outbreak

The U.S. Food and Drug Administration (FDA) has expanded its warning about moringa powder capsules sold under the Rosabella brand after linking them to a multistate outbreak of Salmonella Newport infections. The capsules are distributed by Ambrosia Brands LLC.

So far, seven people across seven U.S. states—Arizona, Florida, Iowa, Illinois, Indiana, Tennessee, and Washington—have fallen ill between November 2025 and January 2026. Three patients required hospitalization, although no deaths have been reported.

Health officials say the outbreak strain is extensively drug-resistant, meaning it does not respond to commonly recommended antibiotics for Salmonella treatment.

The FDA has urged the company to recall all Rosabella moringa capsules, though the firm has agreed to recall only certain lots while the investigation continues. Authorities are tracing the source of contamination and collecting samples.

The affected products were sold online and distributed internationally, including to consumers in the United States and many other countries. Consumers who have purchased the capsules are advised not to consume them and to discard or return the product immediately.

05-03-2026